The efficacy of the new Oxford corona vaccine is questionable, South Africa announces the suspension of its use | Global | NOWnews today

There are many variants of the new corona pneumonia virus. Among these, the variants in the UK, South Africa, Brazil and elsewhere are of greatest concern to the medical community. The outside world also has doubts about whether the vaccine is sufficient to deal with the variant virus. Some foreign media recently reported that the vaccine (also known as the Oxford vaccine) jointly developed by the University of Oxford in the UK and AstraZeneca has a limited effect on mild illness caused by the South African variant virus. South African officials have announced a suspension of the use at 7th local time.

According to extensive foreign media reports, the British “Financial Times” cited on the 6th the results of the University of Oxford and the Golden Mountain University of South Africa on 2026 issues showing that, although no one was admitted or died as a result, the effectiveness of Oxford’s vaccine against the South African variant virus is limited. South African Health Minister Zweli Mkhize announced on local 7th time that the local area will stop vaccinating the aforementioned vaccines until professional recommendations from scientists are issued. Prior to this, South Africa had received 1 million doses of the Oxford vaccine produced by the Serum Institute of India last week, and it was originally intended to give priority to medical personnel. Although the Oxford Vaccine vaccination card in South Africa, Mukez revealed on the 5th that South Africa will receive 9 million doses of the vaccine developed by the US pharmaceutical company Johnson & Johnson and 20 million doses of the Pfizer vaccine. During the suspension of the Oxford vaccine, other vaccines will not be stopped.

id = “replaceMedia”>

※ 【NOWnews Today News】 reminds you:
In response to the new corona pneumonia epidemic, the Department of Disease Control has continued to strengthen surveillance of the epidemic and border control measures. If you have a fever, cough and other symptoms after entering the country, call “1922“Dedicated line, or”0800-001922And wear a mask as instructed to seek medical treatment as soon as possible, while proactively reporting travel history and contact history to the doctor to facilitate timely diagnosis and notification.